Neuro Care Team: Social Worker - Part 2
In part 2 of our 4 part series, Lance Wilson, MSS, LSW, C-SWHC, ASW-G, shares the three most appropriate referrals a social worker can receive from a clinical neurologist.

In part 2 of our 4 part series, Lance Wilson, MSS, LSW, C-SWHC, ASW-G, shares the three most appropriate referrals a social worker can receive from a clinical neurologist.
In part 1 of our 4 part series, Lance Wilson, MSS, LSW, C-SWHC, ASW-G, shares how a social worker's practice can enhance patient care at a neurology clinic.
Dr. Elizabeth Emma Palmer discusses genetic testing in epileptic encephalopathy.
Dr. Page Pennell discusses seizure frequency and treatment during pregnancy.
Dr. Erica Marini discusses drug interactions between MAOIs and antidepressants
In part 3 of a 3 part series, Dr. Karl Krecke discusses his article, “Neuroimaging of Spinal Cord and Cauda Equina Disorders” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/NeuroimSC.
In part 2 of a 3 part series, Dr. Karl Krecke discusses his article, “Neuroimaging of Spinal Cord and Cauda Equina Disorders” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/NeuroimSC.
In part 1 of a 3 part series, Dr. Karl Krecke discusses his article, “Neuroimaging of Spinal Cord and Cauda Equina Disorders” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/ NeuroimSC.
Dr. Jason Crowell shares what to expect at the upcoming 2021 AAN Virtual Annual Meeting. Register by March 25th for the best rates! Show references: https://www.aan.com/conferences/annual-meeting/
Dr. Stacey Clardy talks with Dr. Anthony Amato about bimagrumab in sporadic inclusion body myositis.
Dr. Daniel Correa discusses his NeuroByte, "Bones, Vitamins, & Long-Term Anti-Seizure Medications Management". Show references: https://learning.aan.com/diweb/catalog/item?id=6332338
Dr. Rae Bacharach discusses an article from Neurology: Clinical Practice, "Pregnancy-related and Perinatal Outcomes in Women with MS A Nationwide Danish Cross-sectional Study". Show references : https://cp.neurology.org/content/early/2021/02/03/CPJ.00000000000010 35
In part 3 of a 3 part series, Dr. Shuvro Roy discusses the article, "Neurotoxicity of Cancer Therapies" from the December 2020 issue of Continuum. Show references: https://journals.lww.com/continuum/Abstract/2020/12000/Neurotoxicity_of_Cancer_Therapies.12.as px
In part 2 of a 3 part series, Dr. Shuvro Roy discusses the article, "Neurotoxicity of Cancer Therapies" from the December 2020 issue of Continuum. Show references: https://journals.lww.com/continuum/Abstract/2020/12000/Neurotoxicity_of_Cancer_Therapies.12.asp x
In part 1 of a 3 part series, Dr. Shuvro Roy discusses the article, "Neurotoxicity of Cancer Therapies" from the December 2020 issue of Continuum. Show references: https://journals.lww.com/continuum/Abstract/2020/12000/Neurotoxicity_of_Cancer_Therapies.12.aspx
Dr. Teshamae Monteith talks with Dr. Paul Mathew on the prevalence of occipital neuralgia at a community hospital-based headache clinic. Show references: https://cp.neurology.org/content/11/1/6
Dr. Jeffrey Ratliff talks with Dr. Roy Alcalay about genetic testing for Parkinson's disease. Show references: https://cp.neurology.org/content/11/1/69
Dr. Daniel Correa discusses the recent NeuroByte he edited entitled, "Social Determinants of Health in Epilepsy". Show references: https://learning.aan.com/diweb/catalog/item?id=6330058
Dr. Halley Alexander discusses the Neurology Today article, "What Neurologists Tell Patients Hesitant to Get the COVID-19 Vaccines" Show references: https://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=1081
Dr. Eoin Flanagan shares what he learned editing the February issue of Continuum on Spinal Cord Disorders.
Dr. Rae Bacharach discusses the Neurology Today article, "Hematopoietic Stem Cell Transplantation Found Safe and Effective for Patients with Stiff Person Spectrum Disorder". Show references: https://journals.lww.com/neurotodayonline/fulltext/2021/01210/hematopoietic_stem_cell_transplantation_found_safe.4.aspx
Dr. Anup Patel discusses a quality improvement project he worked on to improve the availability of seizure rescue medication. Show references: https://n.neurology.org/content/91/18/829
Dr. Jeff Ratliff talks with Dr. Wilson Abdo about prolonged unconsciousness in COVID-19.
Dr. Halley Alexander discusses the article "Association of Epileptic and Non-epileptic Seizures and Changes in Circulating Plasma Proteins Linked to Neuroinflammation". Show references: https://n.neurology.org/content/early/2021/01/25/WNL.0000000000011552
Dr. Sethi discusses his NeuroByte, "Approach to a Patient with Head Drop. Show references: https://learning.aan.com/diweb/catalog/item?id=6112423
In part 3 of a 3 part series, Dr. Nicholas Zalewski discusses his article, “Vascular Myelopathies” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/VascMyelo.
In part 2 of a 3 part series, Dr. Nicholas Zalewski discusses his article, “Vascular Myelopathies” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/VascMyelo.
In part 1 of a 3 part series, Dr. Nicholas Zalewski discusses his article, “Vascular Myelopathies” from the February Spinal Cord Disorders Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at http://continpub.com/VascMyelo.
Dr. Alemseged discusses her paper, "Tenecteplase vs Alteplase in Basilar Occlusion". Show references: https://n.neurology.org/content/early/2021/01/06/WNL.00000000000115 20
Dr. Musiek discusses his paper, "Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease" Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2773648